Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

rhBMP-2 Versus Vivigen, a Novel Cellular Allograft, in Lumbar Fusion Procedures: a Prospective Randomized Controlled Study

NCT03527966 is registered in ClinicalTrials.gov with Virtua Health, Inc. as lead sponsor.

NCT NCT03527966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03527966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
rhBMP-2 Versus Vivigen, a Novel Cellular Allograft, in Lumbar Fusion Procedures: a Prospective Randomized Controlled Study
Lead sponsor
Virtua Health, Inc.
Phase
Phase 4
Overall status
Terminated
Start date
July 3, 2017
Completion date
July 27, 2018
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lumbar spine degeneration